A Phase 3, Multicenter, Double-Masked, Randomized, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)
A Phase 3, Multicenter, Double-Masked, Randomized, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (axitinib implant) in Subjects with Neovascular Age-Related Macular Degeneration
Inclusion Criteria:
Exclusion Criteria:
Los Angeles, California 90017-4886, United States
Palo Alto, California 94303, United States
Santa Barbara, California 93103-4211, United States
Colorado Springs, Colorado 80909, United States
Clearwater, Florida 33761, United States
St. Petersburg, Florida 33711-1141, United States
Durham, North Carolina 27705, United States
Nashville, Tennessee 37203-1596, United States
Abilene, Texas 79606, United States
Bellaire, Texas 77401, United States
San Antonio, Texas 78240-1502, United States
Salt Lake City, Utah 84107-6767, United States